Monograph Details
|
|
Infections & Infestations
> Bacterial infections
|
|
CLEOCIN |
| Manufacturer |
|
Pfizer Labs |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Lincosamide. |
| Generic Name |
|
Clindamycin (as HCl) 75mg+, 150mg+, 300mg; caps; +contains tartrazine. |
| Also |
• CLEOCIN INJECTION
• CLEOCIN PEDIATRIC GRANULES
|
| Indications |
|
Serious susceptible infections where less toxic antibiotics are inappropriate, including respiratory, skin and soft tissue, septicemia, intraabdominal, female pelvic or genital; bone and joint (inj). |
| Children |
|
Take with full glass water. Serious: 8–16mg/kg per day. More severe: 16–20mg/kg per day. Divide into 3–4 equal doses. |
| Adults |
|
Take with full glass water. Serious: 150–300mg every 6 hours. More severe: 300–450mg every 6 hours. |
| Precautions |
|
Not for treatment of meningitis. Discontinue if colitis occurs and treat. Monitor neonates. Allergy. Asthma (75mg, 150mg caps). GI disease (esp. colitis). Monitor blood, renal, and hepatic function in long-term use and in children. Renal or hepatic disease with metabolic aberrations. Pregnancy (Cat.B). Nursing mothers. |
| Interactions |
|
May potentiate neuromuscular blocking agents. May antagonize erythromycin. Antiperistaltic agents may worsen colitis. |
| Adverse Reactions |
|
Pseudomembranous colitis, diarrhea, GI upset, rash, anaphylaxis, jaundice, renal dysfunction, blood dyscrasias, polyarthritis. |
| How Supplied |
Caps 75mg—100
150mg, 300mg—16, 100
Granules (100mL)—1
Inj (2mL, 4mL vials)—25 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
